| Line 6: |
Line 6: |
| | | | |
| | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. |
| − |
| |
| − | <br />
| |
| − | {| class="wikitable" style="margin:auto"
| |
| − | |+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
| |
| − | |-
| |
| − | !'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
| |
| − | !'''Date Assigned to Author'''
| |
| − | !'''Target Completion Date'''
| |
| − | !'''Author Content (Pending or Complete)'''
| |
| − | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
| − | !'''Date of Last Editor Review'''
| |
| − | !'''Notes'''
| |
| − | |-
| |
| − | |CHAPTER 2 (GROWTH FACTOR RECEPTORS AND RELATED SIGNALLING PATHWAYS)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |[[Neurofibromatosis Type 1 (NF1)]]
| |
| − | |Disease
| |
| − | |Ngoni Faya (trainee) + Madina Sukhanova
| |
| − | |7/12/2023
| |
| − | |
| |
| − | |PENDING
| |
| − | |
| |
| − | |Madina Sukhanova (Madina S)
| |
| − | |
| |
| − | |Named based on GTS5 book
| |
| − | |-
| |
| − | |[[Familial Adenomatous Polyposis (APC)]]
| |
| − | |Disease
| |
| − | |Jennifer Laffin
| |
| − | |8/20/2023
| |
| − | |
| |
| − | |PENDING
| |
| − | |
| |
| − | |MS / LS
| |
| − | |
| |
| − | |Named based on GTS5 book
| |
| − | |-
| |
| − | |[[Peutz-Jeghers Syndrome (STK11)]]
| |
| − | |Disease
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |Named based on GTS5 book (page created 12/30/23)
| |
| − | |-
| |
| − | |[[Hereditary Gastric and Breast Cancer Syndrome (CDH1, CTNNA1)]]
| |
| − | |Disease
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |Named based on GTS5 book (page created 12/30/23)
| |
| − | |-
| |
| − | |CHAPTER 3 (OXIDATIVE STRESS RESPONSE AND METABOLISM)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |CHAPTER 4 (CELL CYCLE AND APOPTOSIS PATHWAYS)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |[[Li-Fraumeni Syndrome (TP53)]]
| |
| − | |Disease
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |Named based on GTS5 book (page created 12/30/23)
| |
| − | |-
| |
| − | |CHAPTER 5 (DNA REPAIR AND GENOMIC STABILITY)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |[[Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)]]||Disease||Jennie Thurston
| |
| − | |7/2/2023
| |
| − | |
| |
| − | |PENDING
| |
| − | |
| |
| − | |LS
| |
| − | |
| |
| − | |Named based on GTS5 book
| |
| − | |-
| |
| − | |[[BRCA-Related Cancer Predisposition Syndrome (BRCA1, BRCA2)|''BRCA''-Related Cancer Predisposition Syndrome (''BRCA1'', ''BRCA2'')]]
| |
| − | |Disease
| |
| − | |Constance Albarracin / Katherine Geiersbach
| |
| − | |
| |
| − | |
| |
| − | |PENDING
| |
| − | |
| |
| − | |Katherine Geiersbach
| |
| − | |
| |
| − | |Named based on GTS5 book (page created 12/30/23)
| |
| − | |-
| |
| − | |[[PALB2-Related Cancer Predisposition Syndrome (PALB2)]]
| |
| − | |Disease
| |
| − | |Constance Albarracin / Katherine Geiersbach / Jun Liao
| |
| − | |
| |
| − | |
| |
| − | |PENDING
| |
| − | |
| |
| − | |Katherine Geiersbach
| |
| − | |
| |
| − | |Named based on GTS5 book (page created 12/30/23)
| |
| − | |-
| |
| − | |[[Ataxia-Telangiectasia Syndrome (ATM)]]
| |
| − | |Disease
| |
| − | |Evin Gulbahce / Katherine Geiersbach
| |
| − | |
| |
| − | |
| |
| − | |PENDING
| |
| − | |
| |
| − | |Katherine Geiersbach
| |
| − | |
| |
| − | |Named based on GTS5 book (page created 12/30/23)
| |
| − | |-
| |
| − | |[[CHEK2-Related Hereditary (Breast) Cancer Predisposition Syndrome (CHEK2)]]
| |
| − | |Disease
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |Named based on GTS5 book (page created 12/30/23)
| |
| − | |-
| |
| − | |CHAPTER 6 (TELOMERE MAINTENANCE)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |CHAPTER 7 (EPIGENETIC DRIVERS AND CHROMATIN REMODELLING)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |CHAPTER 8 (RNA REGULATION)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |[[DICER1-Related Tumour Predisposition Syndrome (DICER1)]]
| |
| − | |Disease
| |
| − | |Jennie Thurston
| |
| − | |7/2/2023
| |
| − | |
| |
| − | |PENDING
| |
| − | |
| |
| − | |LS
| |
| − | |
| |
| − | |Named based on GTS5 book
| |
| − | |-
| |
| − | |CHAPTER 9 (PROTEIN REGULATION)
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |
| |
| − | ----<br />
| |
| − | |-
| |
| − | |}
| |
| | {| class="wikitable" style="margin:auto" | | {| class="wikitable" style="margin:auto" |
| | |+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big> | | |+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big> |
| Line 986: |
Line 693: |
| | |[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]] | | |[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]] |
| | |Disease | | |Disease |
| | + | |Nada Assaf |
| | + | |6/11/2024 |
| | | | | | |
| | + | |PENDING |
| | | | | | |
| | + | |Eric McGinnis |
| | | | | | |
| − | | | + | |Named based on GTS5 book |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| | |- | | |- |
| | |[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]] | | |[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]] |
| Line 1,085: |
Line 792: |
| | |[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]] | | |[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]] |
| | |Disease | | |Disease |
| | + | |Nada Assaf |
| | + | |6/11/2024 |
| | | | | | |
| | + | |PENDING |
| | | | | | |
| | + | |Xiaolin (Lynn) Hu |
| | | | | | |
| − | | | + | |Named based on GTS5 book |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| | |- | | |- |
| | |[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]] | | |[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]] |